BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 29724877)

  • 1. Do men with lower urinary tract symptoms have an increased risk of advanced prostate cancer?
    Østerø Í Jákupsstovu J; Brodersen J
    BMJ; 2018 May; 361():k1202. PubMed ID: 29724877
    [No Abstract]   [Full Text] [Related]  

  • 2. What should doctors say to men asking for a PSA test?
    Roland M; Neal D; Buckley R
    BMJ; 2018 Sep; 362():k3702. PubMed ID: 30185529
    [No Abstract]   [Full Text] [Related]  

  • 3. Prostate cancer screening with prostate-specific antigen (PSA) test: a clinical practice guideline.
    Tikkinen KAO; Dahm P; Lytvyn L; Heen AF; Vernooij RWM; Siemieniuk RAC; Wheeler R; Vaughan B; Fobuzi AC; Blanker MH; Junod N; Sommer J; Stirnemann J; Yoshimura M; Auer R; MacDonald H; Guyatt G; Vandvik PO; Agoritsas T
    BMJ; 2018 Sep; 362():k3581. PubMed ID: 30185545
    [No Abstract]   [Full Text] [Related]  

  • 4. Primary Care Physicians Beliefs about Prostate-Specific Antigen Evidence Uncertainty, Screening Efficacy, and Test Use.
    Ross LE; Hall IJ; Howard DL; Rim SH; Richardson LC
    J Natl Med Assoc; 2018 Oct; 110(5):491-500. PubMed ID: 30129508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate cancer screening in New Zealand.
    Gray B
    N Z Med J; 2013 Sep; 126(1383):94. PubMed ID: 24157998
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of Prostate-Specific Antigen Testing Is in the Eye of the Beholder.
    Aaronson DS; Redberg RF
    JAMA Intern Med; 2016 Apr; 176(4):547-8. PubMed ID: 26856746
    [No Abstract]   [Full Text] [Related]  

  • 7. Recent Patterns of Prostate-Specific Antigen Testing for Prostate Cancer Screening in the United States.
    Fedewa SA; Ward EM; Brawley O; Jemal A
    JAMA Intern Med; 2017 Jul; 177(7):1040-1042. PubMed ID: 28437537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary care physicians' use of an informed decision-making process for prostate cancer screening.
    Volk RJ; Linder SK; Kallen MA; Galliher JM; Spano MS; Mullen PD; Spann SJ
    Ann Fam Med; 2013; 11(1):67-74. PubMed ID: 23319508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of GPs' risk attitudes, level of empathy, and burnout status with PSA testing in primary care.
    Pedersen AF; Carlsen AH; Vedsted P
    Br J Gen Pract; 2015 Dec; 65(641):e845-51. PubMed ID: 26541183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Navigating Prostate Cancer Screening in the Real World of Primary Care: The Mirage and the Quicksand.
    Mathew P; Hachem H; Han P
    JAMA Oncol; 2018 Apr; 4(4):453-454. PubMed ID: 29470576
    [No Abstract]   [Full Text] [Related]  

  • 11. PSA testing for prostate cancer: an online survey of the views and reported practice of General Practitioners in the UK.
    Brett J; Watson E; Hewitson P; Bukach C; Edwards A; Elwyn G; Austoker J
    BMC Fam Pract; 2005 Jun; 6(1):24. PubMed ID: 15946386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of primary care referrals to urology. Impact of a protocol on prostate disease and continuing education.
    Sopeña-Sutil R; Tejido-Sánchez A; Galván-Ortiz de Urbina M; Guerrero-Ramos F; García-Álvarez G; Passas-Martínez JB
    Actas Urol Esp; 2015 Jun; 39(5):296-302. PubMed ID: 25554605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate cancer screening practices in a large, integrated health system: 2007-2014.
    Misra-Hebert AD; Hu B; Klein EA; Stephenson A; Taksler GB; Kattan MW; Rothberg MB
    BJU Int; 2017 Aug; 120(2):257-264. PubMed ID: 28139034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in Prostate-Specific Antigen Testing Among Urologists and Primary Care Physicians Following the 2012 USPSTF Recommendations.
    Zavaski ME; Meyer CP; Sammon JD; Hanske J; Gupta S; Sun M; Trinh QD
    JAMA Intern Med; 2016 Apr; 176(4):546-7. PubMed ID: 26857148
    [No Abstract]   [Full Text] [Related]  

  • 15. Prostate-specific antigen screening: An update of physician beliefs and practices.
    Hall IJ; Rim SH; Massetti GM; Thomas CC; Li J; Richardson LC
    Prev Med; 2017 Oct; 103():66-69. PubMed ID: 28793236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PSA testing for men at average risk of prostate cancer.
    Armstrong BK; Barry MJ; Frydenberg M; Gardiner RA; Haines I; Carter SM
    Public Health Res Pract; 2017 Jul; 27(3):. PubMed ID: 28765854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relevance of total PSA and free PSA prescriptions.
    Lamy PJ; Brouillet JP; Bermont L; Fouillet G; Loric S
    Ann Biol Clin (Paris); 2018 Dec; 76(6):659-663. PubMed ID: 30543191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary Care Providers' Intended Use of Decision Aids for Prostate-Specific Antigen Testing for Prostate Cancer Screening.
    Rim SH; Hall IJ; Massetti GM; Thomas CC; Li J; Richardson LC
    J Cancer Educ; 2019 Aug; 34(4):666-670. PubMed ID: 29582364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Summary of the NHG practice guideline 'Lower urinary tract symptoms in men'].
    Blanker MH; Klomp MA; van den Donk M; van der Heide WK; Opstelten W; Burgers JS
    Ned Tijdschr Geneeskd; 2013; 157(18):A6178. PubMed ID: 23635505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EAU Guidelines on the Assessment of Non-neurogenic Male Lower Urinary Tract Symptoms including Benign Prostatic Obstruction.
    Gratzke C; Bachmann A; Descazeaud A; Drake MJ; Madersbacher S; Mamoulakis C; Oelke M; Tikkinen KAO; Gravas S
    Eur Urol; 2015 Jun; 67(6):1099-1109. PubMed ID: 25613154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.